Read this company snapshot
Daily valuation snapshot
Mangoceuticals, Inc. Common Stock: source evidence dated 2026-10-09.
- Daily close (USD)
- $0.42
- Market capitalization (USD)
- $9,101,452.08
- Price / earnings (TTM)
- Not reported
- Price / book
- 0.73
The source values and product destination above identify the example to inspect.
What business is this, and what does its dated valuation mean?
Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.
Daily valuation dataset and column definitionsOpen the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research MGRX in the app
Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research MGRX in the appKeep reporting dates and units beside the answer, and inspect its original citations.
Company overview
Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand; and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. The company markets and sells its products online through its website www.MangoRX.com. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.
Daily valuation snapshot
See the complete daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing MGRX with another company.
| Daily close (USD) | $0.42 |
| Market capitalization (USD) | $9,101,452.08 |
| Price / earnings (TTM) | Not reported |
| Price / book | 0.73 |
No matching rows. Clear the filter to see all records.
Read MGRX's valuation metrics
Company size
Mangoceuticals, Inc. Common Stock's recorded market capitalization is $9,101,452.08. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
MGRX's recorded price-to-book ratio is 0.73. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Mangoceuticals, Inc. Common Stock with Aurora
Use the snapshot above to ask a specific question about MGRX. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow MGRX's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.